Comparison of actual hospital costs versus DRG revenues for in-patient treatment of febrile neutropenia during adjuvant anthracycline plus/minus taxane-based chemotherapy for primary breast cancer.

Jacobs, Volker R

Comparison of actual hospital costs versus DRG revenues for in-patient treatment of febrile neutropenia during adjuvant anthracycline plus/minus taxane-based chemotherapy for primary breast cancer. [electronic resource] - Onkologie 2011 - 614-8 p. digital

Publication Type: Comparative Study; Journal Article

1423-0240

10.1159/000334063 doi


Adult
Aged
Anthracyclines
Antineoplastic Agents--economics
Antineoplastic Combined Chemotherapy Protocols--economics
Breast Neoplasms--drug therapy
Bridged-Ring Compounds--economics
Comorbidity
Diagnosis-Related Groups--economics
Female
Fever--drug therapy
Germany--epidemiology
Health Care Costs--statistics & numerical data
Hospitalization--economics
Humans
Income--statistics & numerical data
Insurance, Health, Reimbursement--economics
Male
Middle Aged
Neutropenia--drug therapy
Prevalence
Taxoids--economics